Sentences with phrase «other cancer patients who»

Not exact matches

Patients who exercised more than others had a lower readmission risks following cancer surgery.

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Since they were approved in 2014, drugs that stimulate the immune system have been giving new hope to patients with melanoma, kidney cancer, lymphoma and other cancers, including famously to President Jimmy Carter, who credited the drug called Keytruda with shrinking tumors that had spread to his brain.

At other points in the hour - long program, Ryan discussed Republican plans for repealing and replacing President Obama's health - care law with a cancer patient who credits the law with saving his life.

I can't imagine how good it must feel to receive some of those emails from cancer patients or others who are sustained by his product.

In New York, Cuomo signed the Compassionate Care Act in July 2014, which legalized medical marijuana for patients who are certified by medical practitioners as having «serious» conditions, including cancer, AIDS, severe chronic pain, severe nausea, and other ailments.

Cuomo, who had previously opposed legalizing medical marijuana, will announce an executive action in his State of the State address Wednesday that will permit just 20 hospitals to prescribe pot for patients with cancer, glaucoma or other serious diseases or conditions, according to the New York Times.

In an accompanying briefing book, the Cuomo administration described who would be eligible: patients with cancer, glaucoma and other specific diseases listed by the Health Department and «who are in a life - threatening or sense - threatening situation.»

«We feel it'll be able to help kill cancer cells in 80 percent of breast cancer patients,» said Dr. Olson, who added that their antibody has the potential to help kill lung, colon, prostate and other cancer cells, too.

Critics say an oils - only approach would provide relief for some kids suffering from seizures, but would be of little benefit to cancer and other patients with chronic pain who use marijuana for immediate relief.

Dr. Marcus E. Martinez, who runs a family medical practice in Hoosick Falls, told the Times Union last year that he and his father, who opened the practice in 1956, have noted rare and aggressive forms of cancer in patients, as well as thyroid disease and other health problems.

That study showed how a similar model can be used to understand immune response in patients with pancreatic cancer who survive longer than others.

Now a University of Colorado Cancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resisCancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resiscancer cells may have been pushed past an important tipping point that offers retinoic acid resistance.

The Chinese trial will enrol patients who have metastatic non-small cell lung cancer and for whom chemotherapy, radiation therapy and other treatments have failed.

Fior and colleagues plan to do that with a larger group of colorectal cancer patients and with patients who have other types of cancer, such as breast cancer.

Because there was only one other published case report about a child with M. velutinosus — a 1 - year - old with brain cancer who had undergone a bone marrow transplant — Kumar notes that he and colleagues were at a loss as to how best to treat their patient.

«Our research paves the way for future clinical trials that screen for AIM2 expression in colon cancer and possibly other cancers to identify patients who may potentially benefit from personalized anti-Akt therapy,» Wilson said.

«One criticism of the PARP drugs is they are not active in patients who have developed resistance to other therapies, but we found veliparib appears to be effective in some platinum - resistant patients with recurrent or persistent disease,» said Robert L. Coleman, MD, lead author of the study and professor and vice chair of clinical research at the University of Texas MD Anderson Cancer Center, Houston.

The combination should be studied in other populations of patients, Adelson added, including those who are newly diagnosed with metastatic breast cancer and those who have already progressed on fulvestrant.

For example, women whose cancer was no longer controlled by letrozole or other aromatase inhibitors, those who had already begun to receive chemotherapy, and premenopausal patients with metastatic disease.

A total of 848 physicians reported on 1,631 women they knew who had been diagnosed with breast cancer, 771 of whom were patients, 381 family members and 474 other social network members.

In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana - Farber Cancer Institute and other organizations report today online in the New England Journal of Medicine.

If so, says Grover Bagby, a hematologist who directs the Oregon Cancer Center at the Oregon Health Sciences University in Portland, further work to decipher the protein's exact function could shed light on how to treat a much larger population of patients with leukemia, certain other forms of cancer, and aplastic aCancer Center at the Oregon Health Sciences University in Portland, further work to decipher the protein's exact function could shed light on how to treat a much larger population of patients with leukemia, certain other forms of cancer, and aplastic acancer, and aplastic anemia.

Abatacept, when added to the standard drug regimen used to prevent GvHD, reduced the occurrence of acute, grade III - IV GvHD from 32 to 3 percent in pediatric and adult patients who underwent mismatched unrelated donor stem cell transplants to treat advanced cancer and other blood disorders.

«Even before the patient completes all of the MRIs, CT scans and other imaging procedures following diagnosis, we can have a recommendation for which drug and dosage to prescribe,» said Kareem Azab, PhD, an assistant professor of radiation oncology at the School of Medicine and the Siteman Cancer Center member who leads the research.

Questions to Ask Studies show that cancer (and other) patients who arm themselves with information typically fare better and experience fewer side effects than those who simply follow doctors» orders, no questions asked.

The researchers also are seeking other potential drug targets in the 50 percent of patients who don't have high levels of the anti-death protein, as well as biomarkers in addition to CA125 that could be used to screen for ovarian cancer.

«This groundbreaking study sets the stage for more exacting research, using the latest genomic technologies and aimed at developing new therapies that could help the tens of thousand of patients who urgently need our help,» said Dr. Nhan Tran, an Associate Professor of TGen's Cancer and Cell Biology Division and the study's other co-senior author.

Alternatively, it may be that PKD patients, who are frequently aware that they have a progressive medical condition and who therefore typically receive close medical care for many years or decades, engage in other healthy behaviors that prevent cancer.

Lead author Wayne Ray, Ph.D., and colleagues with the Vanderbilt Department of Health Policy studied Tennessee Medicaid patients between 1999 - 2012 with chronic pain, primarily back and other musculoskeletal pain, who did not have cancer or other serious illnesses.

The study drilled down in particular on patients who had a high risk of dying from a cause other than prostate cancer within 10 years.

«The goal of this research, and other research like this, is to quickly evaluate and treat patients with cancerous nodules, while never exposing patients who don't have cancer to invasive costly and sometimes risky procedures.»

The study, a retrospective survival analysis, included 229 patients who participated in two randomized, controlled clinical trials focused on relief of constipation for patients receiving palliative care for various types of late - stage cancer and other terminal diseases.

«Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,» says S. Vincent Rajkumar, M.D., of Mayo Clinic Cancer Center, who is one of the aucancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,» says S. Vincent Rajkumar, M.D., of Mayo Clinic Cancer Center, who is one of the auCancer Center, who is one of the authors.

The researchers also analyzed the effects of methylnaltrexone on another 135 patients from the same trials who had advanced illnesses other than cancer, such as congestive heart failure, advanced chronic obstructive pulmonary disease or neurologic diseases.

Of 10 patients with other types of cancer — including pancreatic, prostate, and uterine — who had mismatch repair mutations, in seven their tumors shrank or remained stable; the other three progressed.

Patients with incurable cancer and numerous other serious health conditions who consulted with a palliative care team within two days of hospitalization had significant savings in hospital costs, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai.

Dr James Larkin, a Consultant Medical Oncologist at The Royal Marsden, London, UK, told the 2015 European Cancer Congress [1], that results from the CheckMate 067 phase III clinical trial had already shown that the combination of the two drugs, which target two different pathways that regulate the immune system, improved the progression - free survival in patients with melanoma who had not received any other treatment.

«What we see is an association between shorter periods of progression - free survival and overall survival in patients whose blood has higher levels of hypermethylated DNA, and we can see this very early on, after just four weeks of treatment,» says Sara Sukumar, Ph.D., professor of oncology at the Johns Hopkins University School of Medicine and member of the Kimmel Cancer Center, who developed the test with Johns Hopkins scientist Mary Jo Fackler, Ph.D., and others.

In the Comer Emergency Department, pediatricians, pediatric surgeons, nurses, social workers and other professionals will treat the most complex cases — not only those with traumatic injuries but also patients with all types of severe illnesses who need emergency specialty care, including patients with congenital heart disease, cystic fibrosis, cancer and neurological disorders.

We offer dedicated child - life specialists who work exclusively with our cancer patients, as well as a hospital school program, spiritual care, and a wide array of other support programs.

The five - year survival rate for patients with advanced melanoma who got other treatments was 16.6 percent between 2005 and 2011, according to the National Cancer Institute.

At the University of Chicago Medicine Comprehensive Cancer Center, our expert cancer team includes surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, physical therapists, speech / swallowing therapists and other experts who provide compassionate, patient - centeredCancer Center, our expert cancer team includes surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, physical therapists, speech / swallowing therapists and other experts who provide compassionate, patient - centeredcancer team includes surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, physical therapists, speech / swallowing therapists and other experts who provide compassionate, patient - centered care.

Dr Andreas Behren, who led the ONJCRI research team, said that although extremely rare, it couldn't be predicted which melanoma patients might develop other cancers as a result of their treatment.

Doctors often fail to recommend genetic testing for breast - cancer patients, even those who are at high risk for mutations linked to ovarian and other cancers, according to a study published Tuesday.

New findings published in the Journal of Clinical Oncology reveal that older patients who have undergone cancer surgery are at a higher risk of injuries or other health issues.

The registry tracks the medical history of patients with specific gynecologic cancers who may have been exposed to diethylstilbestrol (DES) or other synthetic hormones while still in their mother's womb.

Hear stories from patients who have recovered from leukemia and other blood cancers thanks to stem cell transplants; the donors who provided stem cells to loved ones; and the medical staff that cared for them before, during, and after the procedure.

Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.

«By preventing this debilitating but little - discussed problem, methylnaltrexone could substantially enhance the quality of the last months of life for terminal cancer patients and others who depend on opioid pain relievers,» said the study's first author Chun - Su Yuan, MD, PhD, assistant professor of anesthesia and critical care at the University of Chicago.

The improvement in cancer specific survival could be clinically important for patients who are younger with few other comorbid illnesses.